Javara rides with Uber to reduce trial participation barriers

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/ArisSu)
(Image: Getty/ArisSu)
Javara is offering transportation for clinical trial participants via Uber Health, which enables patients to schedule prepaid rides up to 30 days in advance of site visits.

Javara’s integrated research organization (IRO) platform​ provides a comprehensive clinical research infrastructure, including the people, technology, processes, and relationships. The full service offering looks to augment a health care system’s existing services or add a new clinical research service line of business.

The Uber Health dashboard (Image: Uber)
The Uber Health dashboard (Image: Uber)

Coordinated by the company’s “Clinical Trial Navigators,” clinical trial patients will now be able to schedule prepaid study visit transportation up to 30 days in advance. Patients are not required to have a smartphone or the Uber app.

“At Javara, we’re working to improve the entire clinical trial experience for patients and to make clinical trials more accessible.

"This begins with identifying the basic challenges clinical trial participants face when choosing to participate in clinical trials and bringing forth solutions,”​ said Linda McCarty, Javara general counsel and privacy officer.

“We’ve heard time and time again that access to dependable and flexible transportation is a barrier for many, which is why we are excited to offer rides for clinical trial participants with Uber Health,” ​she told us.

The transportation service company introduced​ Uber Health in March 2018.

Uber at the time selected Bracket​ as a launch partner for the offering which aims to expedite patient transportation – an oft-cited barrier to clinical trial participation.

In 2017 Continuum Clinical asked Lyft​ to help transport trial subjects to clinical sites in a bid to boost retention. Since then, several other companies including ClinOne​ and Greenphire​ have teamed up with the transportation firm.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars